Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Categories: Government agency news release


FDA release on Intrarosa approval omits important conflict of interest


Steroid treatment for preterm infants: NIH release skimps on data and study limitations


FDA release offers inadequate presentation of auto-inflammatory drug approval


FDA release on hepatitis C drug informs on harms, benefits but is light on evidence


Once again, NIH release on blood pressure targets lacks info on absolute benefits, potential harms

1 5/24/2016

FDA PR release on bladder cancer drug skirts lack of long-term survival data

1 5/10/2016

FDA release on drug for treating Parkinson’s psychosis lacks some key details


NIH release delivers most of the goods on long-term heart surgery outcomes


Release on federally funded anti-smoking campaign describes impressive reach but unclear on cost


Exemplary explanation of study comparing diabetic macular edema treatments